What is the procedural success rate of percutaneous coronary intervention (PCI) for coronary artery disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Success Rate of Percutaneous Coronary Intervention (PCI)

Contemporary PCI achieves procedural success rates of 90-95% overall, with angiographic success exceeding 95% in most cases. 1, 2

Overall Success Rates

Modern PCI demonstrates consistently high success rates across multiple large registries:

  • Angiographic success: 93-99% for stented lesions in contemporary practice 3, 4
  • Procedural success: 90-95% (defined as angiographic success without death, MI, or emergency CABG) 1, 2
  • Clinical success: 92.8% when performed for Class I indications per ACC/AHA guidelines 5

These rates represent substantial improvement from the early balloon angioplasty era (72-74% success) due to advances in stent technology, adjunctive pharmacotherapy, and operator experience 1, 2.

Success Rates by Clinical Context

Standard Lesions

  • De novo native coronary lesions with stenting: 97.5-99% angiographic success 3, 4
  • Non-stented lesions: 86% success rate 3

Complex Lesion Subsets

Chronic Total Occlusions (CTO):

  • Overall CTO success: 77-82% with contemporary techniques 6, 7
  • CTO in STEMI setting: >90% success rate 1
  • Conventional CTO: 65% average success 1
  • Success rates are significantly lower than standard lesions due to technical challenges 8

Elderly Patients (≥65 years):

  • Overall success: 93.5-98% in patients >65 years 9, 8
  • Success rates remain high even in patients >75 years (95-98%) with minimal difference compared to younger patients 9, 8
  • Complication rates are higher despite similar success rates 9

Unprotected Left Main Disease:

  • Procedural success: 95-98% with contemporary stenting techniques 1
  • Technical success is high but long-term outcomes vary by lesion complexity and SYNTAX score 10

Complication Rates (Contemporary Era)

Major complications have declined substantially:

  • Mortality: 0.36-1.27% across registries 3, 4
  • Emergency CABG: 0.2-0.5% (down from 5.8% in early era) 3, 4
  • Myocardial infarction: 1.2-2.8% periprocedural 3
  • Stroke: <0.01% 6

CTO-specific complications:

  • Coronary perforation: 2.9% 6
  • Tamponade: 0.3% 6
  • Death: 0.2% 6

Factors Affecting Success

Predictors of lower success rates include:

  • Chronic total occlusions >3 months duration 3, 7
  • Excessive calcification 11
  • Absence of tapered stump 7, 11
  • Excessive tortuosity 11
  • Degenerated saphenous vein grafts 3
  • Advanced age (though success remains high) 9
  • Multivessel disease 7

Success by ACC/AHA Indication Class

Success rates correlate with guideline-recommended indications:

  • Class I indications: 92.8% clinical success 5
  • Class IIa indications: 91.7% 5
  • Class IIb indications: 89% 5
  • Class III indications: 85.5% 5

This gradient demonstrates that evidence-based patient selection significantly impacts outcomes 5.

Key Clinical Considerations

Procedural success is defined as achieving angiographic success (residual stenosis <20% with TIMI 3 flow for stented lesions, or >20% reduction with <50% residual for non-stented) without death, MI, or emergency CABG. 3, 4

Important caveats:

  • Success rates decline with unsuccessful wire crossing in CTOs, where complication rates increase substantially (perforation 10.7% vs 3.65%, tamponade 1.65% vs 0%) 6
  • Pre-procedural coronary CTA for complex CTOs can improve success rates from 63% to 90% 12
  • Failed PCI procedures carry significantly higher one-year MACE rates (18.8% vs 1.8%) 7

References

Related Questions

When should percutaneous coronary intervention (PCI) be chosen instead of coronary artery bypass grafting (CABG) for coronary artery disease?
In a patient with coronary artery disease who has a mixed‑density plaque in the right coronary artery with moderate stenosis on coronary computed tomography angiography (CCTA) and a negative fractional flow reserve computed tomography (FFR‑CT), what is the next management step?
What is the most significant risk factor for coronary artery disease?
Can occupational exposure to jet fuel, aqueous film‑forming foam (AFFF) containing per‑ and polyfluoroalkyl substances (PFAS), and legacy asbestos increase risk of coronary artery disease?
In a 67‑year‑old male with diabetes, hypertension, Parkinson’s disease, chronic liver disease with portal hypertension, presenting with a 10‑day dry cough, exertional dyspnea, pedal edema, metabolic acidosis and hyperkalaemia while on metformin, telmisartan and carbidopa/levodopa, what medication adjustments and acute management steps should be taken?
By what percentage does consistent condom use reduce the risk of acquiring genital herpes (HSV‑2)?
What additional measures can I take to protect my partner when I have oral HSV‑1 lesions only?
Is it safe to initiate Entresto (sacubitril/valsartan) in a patient with type II cardiorenal syndrome on maintenance hemodialysis?
When should percutaneous coronary intervention (PCI) be chosen instead of coronary artery bypass grafting (CABG) for coronary artery disease?
What are the possible causes of intermittent numbness of the hallux (big toe)?
What is the expected recovery period after a decompensated episode of liver cirrhosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.